WAARDENBURG SYNDROME

Waardenburg Syndrome — accounting for 2-5% of all congenital deafness worldwide, where the clinical presentation ranges from subtle pigmentation differences to profound hearing loss with life-threatening Hirschsprung disease.

Whole genome sequencing evaluates all Waardenburg syndrome genes — PAX3, MITF, SOX10, EDNRB, EDN3, and SNAI2 — providing the subtype classification that determines whether Hirschsprung disease screening is indicated.

PAX3
MITF
SOX10
EDNRB
EDN3

About this condition

Waardenburg Syndrome

Waardenburg syndrome (WS) is a group of auditory-pigmentary syndromes caused by defects in neural crest cell migration and differentiation. Four clinical types are recognized: WS1 (PAX3 — sensorineural hearing loss, heterochromia iridis, white forelock, dystopia canthorum), WS2 (MITF, SOX10, SNAI2 — hearing loss and pigmentation without dystopia canthorum), WS3 (PAX3 — WS1 features plus limb anomalies, Waardenburg-Klein syndrome), and WS4 (SOX10, EDNRB, EDN3 — WS features plus Hirschsprung disease). WS accounts for approximately 2-5% of all congenital sensorineural hearing loss worldwide.

The pigmentary features — white forelock, premature graying, heterochromia iridis (different colored eyes), hypopigmented skin patches — are variable and may be absent or subtle. Many patients present with apparently isolated sensorineural hearing loss without obvious pigmentary changes, making Waardenburg syndrome easy to miss clinically. The key distinguishing feature in WS1/WS3 is dystopia canthorum (laterally displaced inner canthi), measured by the W-index. Hearing loss in WS is usually congenital, bilateral, and sensorineural, though unilateral and mild forms exist.

The critical clinical distinction between WS types is the association of WS4 with Hirschsprung disease — congenital absence of enteric ganglia causing functional intestinal obstruction. SOX10 pathogenic variants not only cause WS4 but can also cause peripheral demyelinating neuropathy (SOX10 is critical for Schwann cell and melanocyte development) and may be associated with progressive neurological deterioration. Identifying the specific WS gene determines the surveillance protocol: PAX3 patients need hearing management; SOX10/EDNRB/EDN3 patients need Hirschsprung screening and neurological monitoring.

SOX10 pathogenic variants cause WS4 with Hirschsprung disease risk and may also cause peripheral demyelinating neuropathy — features not seen with PAX3 or MITF variants. Subtype identification is management-critical.

Gene locus: PAX3 (2q36.1), MITF (3p13), SOX10 (22q13.1), EDNRB (13q22.3), EDN3 (20q13.32)

Six genes cause Waardenburg syndrome. The specific gene determines whether the patient is at risk for Hirschsprung disease and peripheral neuropathy — information that hearing assessment alone does not provide.

SOX10 variants carry Hirschsprung disease risk — PAX3 and MITF variants do not

Hirschsprung disease — congenital intestinal aganglionosis requiring surgical intervention — occurs in Waardenburg syndrome type 4, caused by SOX10, EDNRB, or EDN3 pathogenic variants. It does not occur with PAX3 (WS1/WS3) or MITF (WS2) variants. An infant diagnosed with WS by clinical features or hearing loss evaluation who carries a SOX10 variant requires immediate Hirschsprung disease assessment — rectal suction biopsy, contrast enema — before presenting with life-threatening enterocolitis. Without molecular subtyping, this risk assessment cannot be accurately performed based on clinical features alone, since pigmentary and hearing features overlap between subtypes.

2-5% of congenital deafness is Waardenburg syndrome — molecular diagnosis changes recurrence counseling

For a family whose child has congenital hearing loss, the recurrence risk for subsequent children depends entirely on the underlying genetic cause. Connexin 26 (GJB2) hearing loss is autosomal recessive (25% recurrence). PAX3-related Waardenburg syndrome is autosomal dominant with variable expressivity — each subsequent child has a 50% chance of inheriting the variant, but the severity of hearing loss and pigmentary features is unpredictable. This distinction directly affects family planning decisions and prenatal management. Whole genome sequencing evaluates WS genes alongside GJB2 and other hearing loss genes, providing the comprehensive genetic diagnosis for accurate counseling.

Waardenburg Syndrome — accounting for 2-5% of all congenital deafness worldwide, where the clinical presentation ranges from subtle pigmentation differences to profound hearing loss with life-threatening Hirschsprung disease.

Waardenburg Syndrome

Six genes cause Waardenburg syndrome. The specific gene determines whether the patient is at risk for Hirschsprung disease and peripheral neuropathy — information that hearing assessment alone does not provide.

SOX10 variants carry Hirschsprung disease risk — PAX3 and MITF variants do not

2-5% of congenital deafness is Waardenburg syndrome — molecular diagnosis changes recurrence counseling

Others in Rare Diseases

One test. A lifetime of answers.